MEDICAL MARIJUANA, INC. INVESTMENT AXIM® BIOTECHNOLOGIES, INC. PUBLISHES PRODUCT PIPELINE CHART FOR PHARMA CLINICAL TRIALS PROGRAM
Cannabinoid Innovator’s Product Pipeline Highlights Timelines of Its Intellectual Property (IP) Protected Cannabinoid-Based Products from Pre-Clinical to NDA for Multiple IndicationsMedical Marijuana, Inc. (OTC: MJNA) today announced that its investment AXIM® Biotechnologies, Inc. (AXIM® Biotech ) (OTC: AXIM), a world leader in cannabinoid research and development, has published a product pipeline chart on its website that highlights the timelines from pre-clinical to a new drug application